Financial Consulate, Inc Becton Dickinson & CO Transaction History

Financial Consulate, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$229.71 - $259.35 $16,768 - $18,932	73 Added 6.2%	1,250 $309,000
Q2 2021 Jul 22, 2021	SELL	$232.65 - $254.58 $12,097 - $13,238	-52 Reduced 4.23%	1,177 $286,000
Q2 2019 Jul 24, 2019	SELL	$217.4 - $246.08 $869 - $984	-4 Reduced 0.32%	1,229 $310,000
Q1 2019 May 01, 2019	BUY	$206.05 - $248.17 $824 - $992	4 Added 0.33%	1,233 $308,000
Q4 2018 Jan 25, 2019	BUY	$204.73 - $257.93 $10,645 - $13,412	52 Added 4.42%	1,229 $277,000
Q2 2018 Jul 27, 2018	SELL	$208.1 - $233.85 $61,597 - $69,219	-296 Reduced 20.1%	1,177 $282,000
Q4 2017 Jan 29, 2018	BUY	$189.0 - $222.64 $278,397 - $327,948	1,473	1,473 $315,000

1,735

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $68.6B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.